David Barker

David Barker

David L. Barker, Ph.D.

Non-Executive Chair and Independent Director

Dr. David L. Barker currently serves on the Boards of Directors of BioNano Genomics and AmideBio, and is Board Member and Chairman at Integrated Diagnostics and IntegenX, Inc. He is a scientific advisor to Illumina, Inc., where he was Vice President and Chief Scientific Officer from 2000 to 2007. He was previously on the Boards of NextBio, which was acquired by Illumina in 2013, and ProteinSimple, which was acquired by Bio-Techne in 2014. Dr. Barker served from 1998 to 2000 as Vice President and Chief Science Advisor at Amersham Biosciences, now part of General Electric. From 1988 to 1998, Dr. Barker held senior positions, including Vice President of Research and Business Development, at Molecular Dynamics, Inc., until the acquisition of Molecular Dynamics by Amersham.

In his academic career, Dr. Barker conducted interdisciplinary research in neurobiology as a postdoctoral fellow at Harvard Medical School, Assistant Professor at the University of Oregon and Associate Professor at Oregon State University. Dr. Barker holds a B.S. with honors in Chemistry from the California Institute of Technology and a Ph.D. in Biochemistry from Brandeis University.

 
You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue